280 related articles for article (PubMed ID: 26575609)
21. A novel protein encoded by a circular RNA circPPP1R12A promotes tumor pathogenesis and metastasis of colon cancer via Hippo-YAP signaling.
Zheng X; Chen L; Zhou Y; Wang Q; Zheng Z; Xu B; Wu C; Zhou Q; Hu W; Wu C; Jiang J
Mol Cancer; 2019 Mar; 18(1):47. PubMed ID: 30925892
[TBL] [Abstract][Full Text] [Related]
22. CBX2 depletion inhibits the proliferation, invasion and migration of gastric cancer cells by inactivating the YAP/β-catenin pathway.
Zeng M; Li B; Yang L; Guan Q
Mol Med Rep; 2021 Feb; 23(2):. PubMed ID: 33313949
[TBL] [Abstract][Full Text] [Related]
23. Expression of VGLL4 and YAP protein in gastric carcinoma tissues and tumor prognosis.
Han XY; Liu HZ; Cai CY; Li XQ; Ju YB; Li YY; Zhang ZG
Minerva Med; 2018 Dec; 109(6):429-435. PubMed ID: 29914241
[TBL] [Abstract][Full Text] [Related]
24. RAC-LATS1/2 signaling regulates YAP activity by switching between the YAP-binding partners TEAD4 and RUNX3.
Jang JW; Kim MK; Lee YS; Lee JW; Kim DM; Song SH; Lee JY; Choi BY; Min B; Chi XZ; Bae SC
Oncogene; 2017 Feb; 36(7):999-1011. PubMed ID: 27425596
[TBL] [Abstract][Full Text] [Related]
25. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
[TBL] [Abstract][Full Text] [Related]
26. Suppression of YAP by DDP disrupts colon tumor progression.
Li K; Guo J; Wu Y; Jin D; Jiang H; Liu C; Qin C
Oncol Rep; 2018 May; 39(5):2114-2126. PubMed ID: 29512779
[TBL] [Abstract][Full Text] [Related]
27. Knockdown of YAP inhibits growth in Hep-2 laryngeal cancer cells via epithelial-mesenchymal transition and the Wnt/β-catenin pathway.
Tang X; Sun Y; Wan G; Sun J; Sun J; Pan C
BMC Cancer; 2019 Jul; 19(1):654. PubMed ID: 31269911
[TBL] [Abstract][Full Text] [Related]
28. A novel role for microRNA-129-5p in inhibiting ovarian cancer cell proliferation and survival via direct suppression of transcriptional co-activators YAP and TAZ.
Tan G; Cao X; Dai Q; Zhang B; Huang J; Xiong S; Zhang Yy; Chen W; Yang J; Li H
Oncotarget; 2015 Apr; 6(11):8676-86. PubMed ID: 25895125
[TBL] [Abstract][Full Text] [Related]
29. Oncogenic USP22 supports gastric cancer growth and metastasis by activating c-Myc/NAMPT/SIRT1-dependent FOXO1 and YAP signaling.
Liu H; Liu N; Zhao Y; Zhu X; Wang C; Liu Q; Gao C; Zhao X; Li J
Aging (Albany NY); 2019 Nov; 11(21):9643-9660. PubMed ID: 31689236
[TBL] [Abstract][Full Text] [Related]
30. Leukemia inhibitory factor promotes gastric cancer cell proliferation, migration, and invasion via the LIFR-Hippo-YAP pathway.
Bian SB; Yang Y; Liang WQ; Zhang KC; Chen L; Zhang ZT
Ann N Y Acad Sci; 2021 Jan; 1484(1):74-89. PubMed ID: 32827446
[TBL] [Abstract][Full Text] [Related]
31. IL-6 Triggers the Migration and Invasion of Oestrogen Receptor-Negative Breast Cancer Cells via Regulation of Hippo Pathways.
Hou L; Xie S; Li G; Xiong B; Gao Y; Zhao X; Hu J; Deng S; Jiang J
Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):549-557. PubMed ID: 29781562
[TBL] [Abstract][Full Text] [Related]
32. Essential Oil from
Zhang Y; Xin C; Qiu J; Wang Z
Molecules; 2019 Oct; 24(21):. PubMed ID: 31731517
[TBL] [Abstract][Full Text] [Related]
33. Alternate RASSF1 Transcripts Control SRC Activity, E-Cadherin Contacts, and YAP-Mediated Invasion.
Vlahov N; Scrace S; Soto MS; Grawenda AM; Bradley L; Pankova D; Papaspyropoulos A; Yee KS; Buffa F; Goding CR; Timpson P; Sibson N; O'Neill E
Curr Biol; 2015 Dec; 25(23):3019-34. PubMed ID: 26549256
[TBL] [Abstract][Full Text] [Related]
34. WBP2 promotes gastric cancer cell migration via novel targeting of LATS2 kinase in the Hippo tumor suppressor pathway.
Hum M; Tan HJ; Yang Y; Srivastava S; Teh M; Lim YP
FASEB J; 2021 Feb; 35(2):e21290. PubMed ID: 33475198
[TBL] [Abstract][Full Text] [Related]
35. Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis.
Tanaka K; Osada H; Murakami-Tonami Y; Horio Y; Hida T; Sekido Y
Cancer Lett; 2017 Jan; 385():215-224. PubMed ID: 27773750
[TBL] [Abstract][Full Text] [Related]
36. Regulation of the Hippo/YAP axis by CXCR7 in the tumorigenesis of gastric cancer.
Wang T; Wang D; Sun Y; Zhuang T; Li X; Yang H; Zang Y; Liu Z; Yang P; Zhang C; Cui J; Fu M; Zhang S; Su P; Li Z; Zhu J; Ding Y
J Exp Clin Cancer Res; 2023 Nov; 42(1):297. PubMed ID: 37950281
[TBL] [Abstract][Full Text] [Related]
37. KIF23 activated Wnt/β-catenin signaling pathway through direct interaction with Amer1 in gastric cancer.
Liu Y; Chen H; Dong P; Xie G; Zhou Y; Ma Y; Yuan X; Yang J; Han L; Chen L; Shen L
Aging (Albany NY); 2020 May; 12(9):8372-8396. PubMed ID: 32365332
[TBL] [Abstract][Full Text] [Related]
38. The dual functions of YAP-1 to promote and inhibit cell growth in human malignancy.
Wang H; Du YC; Zhou XJ; Liu H; Tang SC
Cancer Metastasis Rev; 2014 Mar; 33(1):173-81. PubMed ID: 24346160
[TBL] [Abstract][Full Text] [Related]
39. MST4 kinase suppresses gastric tumorigenesis by limiting YAP activation via a non-canonical pathway.
An L; Nie P; Chen M; Tang Y; Zhang H; Guan J; Cao Z; Hou C; Wang W; Zhao Y; Xu H; Jiao S; Zhou Z
J Exp Med; 2020 Jun; 217(6):. PubMed ID: 32271880
[TBL] [Abstract][Full Text] [Related]
40. Yes-associated protein enhances proliferation and attenuates sensitivity to cisplatin in human gastric cancer cells.
Lu T; Sun L; Zhu X
Biomed Pharmacother; 2018 Sep; 105():1269-1275. PubMed ID: 30021363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
